Skip to main content
Lindsey Baden, MD, Infectious Disease, Boston, MA

LindseyRobertBadenMD

Infectious Disease Boston, MA

Associate Professor of Medicine, Brigham and Women's Hospital

Are you Dr. Baden?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
    You already have 119 invites waiting!
  • Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

  • Office

    75 Francis St
    # Brigham
    Boston, MA 02115
    Phone+1 617-732-8881

Summary

  • Dr. Lindsey Baden, MD is an infectious disease specialist in Boston, Massachusetts. He is currently licensed to practice medicine in Massachusetts, Rhode Island, and Maine. He is affiliated with Brigham and Women's Hospital and Dana-Farber Cancer Institute.

Education & Training

  • Beth Israel Deaconess Medical Center
    Beth Israel Deaconess Medical CenterFellowship, Infectious Disease, 1995 - 1999
  • Beth Israel Deaconess Medical Center
    Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1992 - 1995
  • Albert Einstein College of Medicine
    Albert Einstein College of MedicineClass of 1992

Certifications & Licensure

  • ME State Medical License
    ME State Medical License Current
  • MA State Medical License
    MA State Medical License 1994 - 2025
  • RI State Medical License
    RI State Medical License 2022 - 2024
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Infectious Disease

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • I’m Worried About Going to Hospitals Without a Mask
    I’m Worried About Going to Hospitals Without a MaskMay 10th, 2023
  • All Thumbs up from FDA Panel for Bacterial Pneumonia Therapy
    All Thumbs up from FDA Panel for Bacterial Pneumonia TherapyApril 18th, 2023
  • Advisors to the US Food and Drug Administration (FDA) Recommend Full Approval of Pfizer’s Covid Drug Paxlovid
    Advisors to the US Food and Drug Administration (FDA) Recommend Full Approval of Pfizer’s Covid Drug PaxlovidMarch 17th, 2023
  • Join now to see all